Spanish stocks - Factors to watch on June 2

Reuters
02 Jun
Spanish stocks - Factors to watch on June 2

June 2 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

MAPFRE MAP.MC

Mapfre was selected with three other insurers by telecom company Masorange as finalists to supply insurance products to its customers, Spanish newspaper Expansion reported on Monday.

INDRA IDR.MC

Indra secured regulatory approvals to take over armoured-vehicle maker Tess Defence, Expansion said on Friday, citing unnamed sources. The company will spend 100 million euros ($113.79 million) to buy shares held by its partners Escribano M&E, Sapa Plasencia and Santa Barbara Sistemas which will allow it to raise its stake in Tess Defence above 50%, Expansion reported.

PharmaMar PHMR.MC

PharmaMar, through Jazz Pharmaceuticals, expects to receive approval from the US Food and Drug Administration (FDA) to sell Zepzelca, its lung cancer drug, in the first line, as the first treatment to be recommended to patients, El Economista reported on Saturday.

For today's European market outlook double click on .EU.

For real-time moves on the Spanish blue-chip index IBEX please double click on .IBEX

For IBEX constituent stocks highlight .IBEX in the command box and press the F3 button on your keyboard

For latest news on Spanish stock moves double click HOT-ES

For Spanish language market report double click on .MES

For latest Eurostocks report please double click on .EU

($1 = 0.8788 euros)

(Gdansk Newsroom; Gdansk.newsroom@thomsonreuters.com+48 58 769 66 00)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10